Bioprosthetic Valve Failure: TAVR Clinical and Hemodynamic Results From the VIVID Registry and Other Studies

Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and Special Considerations for TAVR

Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial

Low-Risk Studies: Design and Updates I - The UK All-Comer TAVI Study

Intermediate-Risk Studies II: Updates From SURTAVI

Intermediate-Risk Studies I: Synthesis of the PARTNER 2A and the Sapien 3 Intermediate-Risk Trials

Flash Debate: Point – Guidelines Should Remain the Standard for Clinical Practice!

Future TAVR Guidelines: The Next ACC/AHA TAVR Focused Update and New Appropriate Use Criteria for TAVR

Case #1: Coronary Obstruction Following Transcatheter Valve in Valve: What I Learned

Debate: TAVR for Low Risk Patients – Is It time? YES, the Data Is Sufficient and Our Patients Want It!